Vitamin D testing

Increased interest in vitamin D deficiency, reports of its high prevalence in Australia and a suggested role in a range of health conditions has led to a surge in vitamin D testing and uncertainty about management. This issue has been the subject of an increasing number of consumer and health professional publications.

Since 2004/2005 there has been a ten-fold increase in the number of referrals for vitamin D tests. The greatest growth in vitamin D testing has occurred in people aged from 20 to 39 years. While current  Australian guidelines recommend vitamin D testing in a range of well-defined ´at risk´ populations (for example veiled women and people who are either institutionalised, elderly or dark-skinned), the consequences of routine testing in low-risk populations are unclear.

The NPS MedicineWise program about Preventive Activities in General Practice discusses why vitamin D tests may not be appropriate to request routinely for healthy people aged 40–49 who have no known risk factors.

For more information

Related information -

Audience:
       

(Medicine)
19 Jan 2017 Find out about Celazadine Powder for injection. Plus information and tips on how to use medicines wisely and safely.
(Medicine)
19 Jan 2017 Find out about Azonaire Hayfever Nasal Spray. Plus information and tips on how to use medicines wisely and safely.
(Medicine)
19 Jan 2017 Find out about Atomoxetine Amneal Capsules. Plus information and tips on how to use medicines wisely and safely.
For health professionals (CPD activity)
16 Jan 2017 General practitioners (GPs) can keep up to date with the latest structured approach to help clarify where the newer options, including fixed-dose combination inhalers, fit within the latest COPD-X management guidelines. Book a free educational visit now.
(Medicine)
05 Jan 2017 Information on medicines available in Australia containing amphotericin B (phospholipid complex), including our latest evidence-based information and resources for health professionals and consumers. The active ingredient is the chemical in a medicine that makes it work. Medicines that contain the same active ingredient can be available under more than one brand name. Brands include both active ingredients and inactive ingredients. You'll find information about brands of medicines that contain amphotericin B (phospholipid complex) below, including their consumer medicine information (CMI) leaflets.
(Medicine)
05 Jan 2017 Find out about Irinotecan Accord Concentrate for infusion. Plus information and tips on how to use medicines wisely and safely.
(Medicine)
05 Jan 2017 Find out about Doxorubicin ACC Concentrate for infusion. Plus information and tips on how to use medicines wisely and safely.
(Medicine)
05 Jan 2017 Find out about Tropisetron MYX Solution for injection. Plus information and tips on how to use medicines wisely and safely.
(Medicine)
05 Jan 2017 Information on medicines available in Australia containing amphotericin B (amphotericin) (antifungal medicines), including our latest evidence-based information and resources for health professionals and consumers. The active ingredient is the chemical in a medicine that makes it work. Medicines that contain the same active ingredient can be available under more than one brand name. Brands include both active ingredients and inactive ingredients. You'll find information about brands of medicines that contain amphotericin B (amphotericin) (antifungal medicines) below, including their consumer medicine information (CMI) leaflets.
(Medicine)
05 Jan 2017 Information on medicines available in Australia containing dactinomycin (actinomycin D), including our latest evidence-based information and resources for health professionals and consumers. The active ingredient is the chemical in a medicine that makes it work. Medicines that contain the same active ingredient can be available under more than one brand name. Brands include both active ingredients and inactive ingredients. You'll find information about brands of medicines that contain dactinomycin (actinomycin D) below, including their consumer medicine information (CMI) leaflets.